TOYO TOYO Co., Ltd
$4.64
TOYO Co., Ltd Q3 F2026 Earnings Call Transcript
AI Conference Call Analysis
Sign in or subscribe to read.Matt
Conference Call Operator
Hello everyone. Thank you for joining us and welcome to TOYO third quarter and first nine months, 2026 financial results conference call. After today's prepared remarks, we will host a question and answer session. If you would like to ask a question, please press star one to raise your hand. To withdraw your question, press star one again. I will now hand the conference over to Crocker Colson. Crocker, please go ahead.
Crocker Colson
Investor Relations
Thank you, Matt. Hello, everyone. Thank you so much for joining us to review Toyo's third quarter and first nine months 2026 results. This morning, Toyo posted both the earnings release and a related investor presentation to our website, which you can find at investors.toyo-solar.com. With us today on the call are Takahiko Onozuka, TOYO's Chairman and Chief Executive Officer, Rhone Resch, TOYO's Chief Strategy Officer, and Yasunari Harada, TOYO's Chief Financial Officer. We also have Simon Shi, Senior Advisor to the Board, who will be available during the Q&A portion of this call. After the prepared remarks are concluded, We're going to open up this call for your questions. But before we begin, the financial results discussed on this call for the third quarter of 2026 and the first nine months of 2026 and the corresponding periods of 2025 are unaudited. And some statements in this teleconference are forward-looking within the meaning of federal securities laws. include statements about our module business outlook, expected solar module deliveries and solar cell supply, the resumption of sales to U.S. customers, our HJT cell line, the Section 232 program in our discussions with Department of Commerce, and the Commerce Circumvention Inquiry. Although we believe these statements are reasonable, We can provide no assurance that they will ultimately prove to be accurate because they are perspective in nature. During this call, we will also discuss certain non-GAAP financial measures, such as adjusted EBITDA and adjusted net income. Reconciliations to the most directly comparable GAAP measures are included in our earnings release. Actual results could differ materially from those we discussed today. We therefore encourage you to review our most recent annual report on Form 20F, Form 6K, and other SEC filings for risk factors that could materially impact our results. With those formalities out of the way, it's now my great pleasure to turn this call over to Onozuka-san, TOYO's Chairman and CEO. Onozuka-san, please take it away.
Takahiko Onozuka
Chairman and Chief Executive Officer
Thank you, Crocker. In the third quarter, U.S. trade proceedings affecting solar cells from our Ethiopia facility disrupted our cell business. Even though we remained profitable, third quarter revenue increased 57.3% year over year, and our U.S. module business continued to expand. For the first nine months, Revenue increased 42.0% and net income nearly doubled. We also made real operational progress. We completed our second module line in Humboldt, Texas, bringing capacity there to approximately 2 gigawatts. And we marked milestone at our October 6th ribbon cutting and solar analysis day. Rhone will take you through our trade proceedings and U.S. module business, and our CFO, Harada-san, will review the financials in detail. We remain committed to full transparency in our supply chain and to build a long-term manufacturing platform in the United States. I will now turn the call over to our CFO, Rhone Resch.
Rhone Resch
Chief Strategy Officer
Thank you, Onozuka-san, and good morning, everyone. I will focus on four areas that are central to Toyo's strategy in the United States – the continued growth of our U.S. module business, the Section 232 process, our planned HJT cell investment in Texas, and the trade proceedings affecting cells produced in Ethiopia. Taken together, these developments show how Toyo is executing on a clear strategy Expanding U.S. manufacturing, building a more transparent and resilient non-FEOC supply chain, and reducing our exposure to the trade uncertainty affecting imported solar products. Our opportunity is significant. Demand for domestically manufactured solar products continues to strengthen. U.S. policy is increasingly supporting onshore production, and TOYO is positioning itself to participate in that transition at scale. Let me begin with our U.S. module business, which continues to be an important source of growth and increasingly provides greater visibility into our future revenue. As Onozuka-san mentioned, on October 6th, we held a ribbon-cutting ceremony and Solar Analyst Day at our Houston-area facility in Humboldt, Texas, marking the completion of our expansion to approximately 2 gigawatts of module manufacturing capacity. We were honored to be joined by Jeffrey Kessler, Undersecretary of Commerce for Industry and Security, Takeshi Koyama, Consul General of Japan and Houston, Congressman Christian Menefee, and Paul Wormser of CEA Intertech, along with customers, partners, analysts, and investors. It was really a fun event. For TOYO, this expansion represents an important milestone. We now have a meaningful U.S. manufacturing platform operating at scale, supported by a growing workforce, strong customer demand, and continued engagement with federal, state, and local stakeholders. Our U.S. module business continues to expand during the third quarter. We delivered 277.4 megawatts of modules during the quarter, and 469 megawatts during the first nine months of the year. With our second production line now complete, our Houston area module facility has approximately two gigawatts of nameplate capacity. Importantly, customer demand is translating into contracted business. Since mid-June, we have entered into multiple binding module supply agreements with U.S. customers representing an aggregate value of approximately $240 million. Deliveries began during the third quarter and are scheduled to continue through the first half of 2027. This gives us meaningful visibility into our U.S. module business as we enter 2027. We have also taken steps to protect these customer commitments from the trade uncertainty affecting our Ethiopian cell operations. We have secured non-FEOC cell supplies from outside Ethiopia sufficient to support our committed U.S. module deliveries through 27. That is an important point for investors. While the trade proceedings have created uncertainty for our cell business, they have not stopped the continued ramp of our U.S. module operations or our ability to meet our committed customer deliveries. As I mentioned, demand for U.S. modules supported by a transparent, non-FEOC supply chain remains strong. And that is exactly the manufacturing platform that we are building in Texas. Turning to trade policy, on August 6th, the President issued a Section 232 proclamation covering imports of polysilicon and downstream solar products. We believe this action reinforces the importance of developing a stronger domestic solar manufacturing base and is closely aligned with TOYO's long-term strategy in the United States. TOYO has submitted a proposal to the Department of Commerce for an offset agreement designed to support our multi-year U.S. investment plan, including our planned HJT facility and the potential expansion of our U.S. manufacturing footprint into upstream solar products. We are currently engaged with Commerce regarding the terms of that proposal. Any agreement, including eligible products, volumes, timing, and other conditions, remains subject to Commerce's approval, and we therefore cannot quantify the potential financial impact at this stage. However, the strategy objective is clear. We want to align Toyo's substantial U.S. manufacturing investment with U.S. trade policy in a way that accelerates domestic production and strengthens the U.S. solar supply chain. And polysilicon sourcing is an important part of that strategy. For products serving the U.S. market, we currently source polysilicon entirely from non-Chinese suppliers, including suppliers in the United States and OCI in Malaysia. U.S. produced polysilicon represents the majority of the polysilicon that we use for our Ethiopian cell plant. This supports our broader objective of building a supply chain that is increasingly anchored in the United States and with allied countries. Our next major step in that strategy is domestic solar cell manufacturing. We continue to develop a 1.5 gigawatt heterojunction or HJT solar cell line at our Houston area site in Humboldt, Texas. The planned investment is approximately $357 million and we continue to expect pilot production no later than the first quarter of 2028. We recognize that investors will naturally focus on the capital requirements associated with a project of this scale. The timing and pace of the investment will remain aligned with non-dilutive financing, availability, and other capital resources. We intend to pursue the project in a disciplined manner while maintaining appropriate liquidity for our existing operations. Strategically, this facility is very important for Toyo. It will bring next generation cell manufacturing and R&D onto the same U.S. campus as our module operations and further reduce our reliance on imported cells. It is also a central component of the broader U.S. manufacturing plan we are discussing with the Department of Commerce. Our objective is not simply to assemble modules in the United States. Over time, we intend to build a more integrated U.S. manufacturing platform around advanced solar technology. Let me now address the trade proceedings affecting our Ethiopian operations. During the third quarter, shipments of solar cells from our Ethiopian facility were affected by U.S. Customs and Border Protection examination. We work closely and cooperatively with CBP and provided detailed information regarding our supply chain. I am pleased to report that all shipments affected by that examination have now been released. And we are pursuing certification under CBP's Customs Trade Partnership Against Terrorism, or CTPAT, a program that further strengthens the security and transparency of our supply chain. However, the release of those shipments does not resolve the separate U.S. Department of Commerce circumvention inquiry concerning solar cells completed in Ethiopia, which was initiated on July 17th of this year and remains ongoing. Our U.S. module operations remain protected. As I mentioned earlier, we have secured non-feox cell supply from outside Ethiopia sufficient to meet our committed U.S. module deliveries through 2027. That allows us to continue serving our U.S. customers while the commerce process proceeds. So now I want to talk a little bit about the anti-circumvention inquiry. As I mentioned on July 17th, the Department of Commerce initiated a countrywide circumvention inquiry concerning certain solar cells and modules completed in Ethiopia using parts or components from China. Thankfully, Commerce selected Toyo as a mandatory respondent, and we have submitted our initial questionnaire response. That submission provides detailed information regarding our sourcing, investment, manufacturing operations, and the value added through our production process in Ethiopia. We are cooperating fully with Commerce and will continue to provide all information required as part of its review. One important fact in Toyo's case is that we do not use Chinese origin wafers in our Ethiopian cell production. The use of Chinese origin wafers and other Chinese components was a significant factor in prior solar circumvention proceedings, making our wafer sourcing an important distinction in the factual record. Ultimately, Commerce will evaluate the complete record, and we cannot predict either the outcome or the timing of the inquiry. We remain confident in the facts supporting Toyo's supply chain and will continue to work constructively with Commerce throughout the process. As we move forward, our priorities are clear. Deliver on our contracted U.S. module business, maintain transparent and traceable supply chains, manage trade risk carefully, and continue expanding advanced manufacturing in the United States. Despite the trade uncertainty affecting our cell business, we are building a larger, more diversified, and increasingly U.S.-based manufacturing platform. We believe that positions Toyo well for the direction in which both the market and U.S. policy are moving. I will now turn the call over to our CFO, Yasunari Harada, to review our financial results in more detail. Harada-san.
Yasunari Harada
Chief Financial Officer
Thank you, Ron. And sub-quarter revenue was 129.0 million U.S. dollars, down 4.8 percent from 135.6 million U.S. dollars a year earlier and up 9.2% from the second quarter of 2026. By-product sales were 49.4 million U.S. dollars, module sales 55.4 million U.S. dollars, and wafer sales, which began in July. 24.3 million U.S. dollars, third-party revenue grew 57.3% to 112.1 million U.S. dollars, and related party revenues was 17.0 million U.S. dollars. Cost of revenues was 107.6 million U.S. dollars, from $100.8 million. Gross profit was $21.5 million, for a gross margin of 16.6%, compared with 25.7% a year earlier, and 31.3% in the second quarter. The decrease in gross margin mainly reflected the change in our sales mix. As solar cell sales decreased and solar module sales increased, our solar module business continued to generate double-digit growth margin. Income tax expense was $0.6 million, down from $5.8 million, reflecting lower taxable income and preferential 5% rate for our Singapore subsidiary effective June 1, 2026. Net income was 4.3 million U.S. dollars versus 22.6 million U.S. dollars a year earlier. Non-GAAP adjusted EBITDA was 19.5 million U.S. dollars. And adjusted net income was 4.5 million U.S. dollars. Basic and diluted EPS were $0.10 compared with $0.66. Turning to the first nine months of 2026, revenue was $390.0 million, up 42.0% from 274.7 million U.S. dollars a year earlier. Growth came mainly from module sales of 101.2 million U.S. dollars, OEM service revenue of 37.2 million U.S. dollars, and the new wafer sales partially offset of lower sales sales. Gross profit was 106.2 million U.S. dollars at 83.4% from 57.9 million U.S. dollars for a gross margin of 27.2% compared with 21.1% a year earlier. Operating expenses were 42.1 million U.S. dollars compared with 19.5 million U.S. dollars, deflecting additional staff at our Ethiopia and Texas plants and higher legal and professional fees related to trade and regulatory matters. Net income was 50.1 million U.S. dollars, up 99.5% from 25.1 million U.S. dollars. Non-GAAP adjusted EBITDA was 102.1 million U.S. dollars and adjusted net income was 50.7 million U.S. dollars. Basic EPS was 1.27 U.S. dollars and diluted EPS was 1.26 U.S. dollars compared with 0.66 U.S. dollars a year earlier. Under Balanced, we ended the quarter with 74.0 million U.S. dollars in cash and restricted cash, including 64.9 million U.S. dollars of unrestricted cash, up from 58.9 million U.S. dollars at year-end. Nine months operating cash flow was 35.2 million USD and we invested 44.1 million USD in property and equipment. With our Houston solar module capacity substantially committed for 2027, we expect our Texas solar module operation to operate at or near full capacity next year. Given the continuing uncertainty related to the Commerce circumvention inquiry and the Section 232 program, which principally affects sales shipment, we are not providing quarterly guidance for our solar cell business, specific guidance on revenue, net income, or other metrics at this time. That concludes the financial review. Thank you.
Crocker Colson
Investor Relations
I think we're ready for the question and answer session.
Matt
Conference Call Operator
We will now begin the question and answer session. If you would like to ask a question, please press star one to raise your hand. To withdraw your question, press star one again. We ask that you pick up your handset when asking a question to allow for optimum sound quality. If you are muted locally, please remember to unmute your device. Please stand by while we compile the Q&A roster. Your first question comes from the line of Amit Dayal with HC Wainwright. Amit, your line is open. Please go ahead.
Amit Dayal
Analyst, HC Wainwright
Thank you. Good morning, everyone, and congrats on a pretty solid quarter despite some of the export controls issues you are navigating. My question on that front is, is there any one type of determination that the CBP will make that will allow you to get out of this overhang a little bit? Or are you just navigating this process as the CBP undergoes its own diligence on this? How should we think about how this potentially gets resolved for you going into 2027?
Rhone Resch
Chief Strategy Officer
Yeah, thanks, Amit.
Crocker Colson
Investor Relations
and maybe distinguish between CBP and the circumvention, just to make that clear for the listeners.
Rhone Resch
Chief Strategy Officer
Yeah, exactly. Thanks, Gregor. Yeah, good morning, Amit. So the CBP process is fairly straightforward. They are evaluating if any forced labor was used in the production of solar cells. Most of the companies who import into the United States go through this process. and and it's um you know it takes time you have to obviously produce information that not only shows your supply chain but from your suppliers your polysilicon suppliers uh the information all the way back to where the quartzite was actually mined right so there's many different participants in this process that provide information to CBP so it does take a little bit of time We have obviously a very close relationship with our polysilicon providers. They've gone through this process before. They provided all the information to CBP. We've met with CBP multiple times, both in person and on Zoom calls. And we have been very open and transparent with them on all the information that they're looking for. So I would say that we've developed a very clear line of communication. We have conversations. Very clear controls within the company. We're very disciplined about tracking and having the information available on all of our supply chain. And in this case, we provided it to them. So CBP has released all of the detentions that we had. So, again, I would say ongoing, we're going to continue to provide them with any information that they have. But there are no detentions at this point. And as I mentioned, we are applying for the CTPAT process. It's fairly rigorous. Very few solar manufacturers in the U.S. have it, but we're committed to it. And that CTPAT process, again, shows not only a commitment by the company for transparency as well as compliance, but also establishes, let's say, a different level of certification with CBP once you achieve it. So as a company, we're very committed to continuing to work with CVP and make that information available, of course. The second issue is around the circumvention case, and this is separate. This was a case that was filed by a group of companies led by First Solar and was initiated on July 17th. The circumvention case goes through the process where the Department of Commerce sends out a questionnaire to mandatory respondents. Thankfully, we are a mandatory respondent. It gives us a chance to be very open and transparent in providing information about our manufacturing process, our supply chain, etc. And so Commerce sends out the comprehensive questionnaire, which we just completed last week. They will then review that questionnaire and have follow-up questions. And at least at this point in time, they're scheduled to have a preliminary determination by December 17th. We can't really speculate on timing. They often do delay. I think what is clear in this process is that this is not the first circumvention case. There have been multiple cases over time since the original 2012 ADCVD case in China, Solar One, which you'll remember me. And in all of those cases, the determining factor was where the wafer originated from. And if you were using a Chinese wafer, you were subject to tariffs. If you're using a non-Chinese wafer, you are not. Those are the previous cases. And again, we cannot determine exactly how commerce will go about this case, but it's pretty straightforward. It is another circumvention case. So from Toyo's perspective, we do not use Chinese wafers at our facility in Ethiopia. All of them come from Indonesia. All of the polysilicon is either U.S. or coming from OCI in Malaysia. But we'll continue to work with the Department of Commerce to provide them whatever information that they need in, obviously, a timely manner. And we'll continue to be very, let's just say, involved in that whole process. Does that answer your question to me?
Amit Dayal
Analyst, HC Wainwright
Yes, yes. Thank you for that clarification. That's very helpful, actually. And we kind of have some kind of a date also to work with on this. So I appreciate that. And then, you know, for the 1.5 AJT capacity coming into play, I guess you're saying potential production in 1Q28. So should we assume, you know, the long lead time equipment, etc., orders for those have already been placed and work to begin sort of setting up that line is already underway? How should we think about the phased capex going into sort of bringing that capacity online?
Rhone Resch
Chief Strategy Officer
Sure, I'll take the first cut at that as well, and if Harada-san or Simon wants to jump in as well. Yes, we have secured the equipment for the facility. We're now at the Houston plant going through the process of permitting. We need more power. We need more water. Junsei Ryu, Aihua Wang, Liang Shi, Rhone Resch, Takahiko Onozuka We built them in Vietnam. We built them in Ethiopia. We have that experience of designing, constructing, and ramping cell facilities. It's not that easy, as many companies are finding out, but specifically, Toyo has executed in our ability to do this in the past. When we look in general about the funding for the HJT plant, we are going to do so in a non-dilutive manner to the greatest extent possible. We believe that we have sufficient operating cash flow from the business. We expect Section 45 tax credits to be an important source of the funding for the HDT line. along with debt financing, operating cash flow, and other non-dilutive sources. So, you know, as we're kind of looking forward to this particular facility, it actually fits in, I think, very nicely with the policy structure that has been created both with respect to tax credits, but also the on-shoring program. And as we look at the 232 structure, the HJT plant is a big part of our proposal to the Department of Commerce. So I'll leave it there, and if you have any additional questions about the HJT line, I'll let you dive in deeper.
Amit Dayal
Analyst, HC Wainwright
No, that was helpful. Thank you. My last question, I guess, is, you know, as you are sort of indicating full capacity utilization for 2027, you know, how should we think about the third-party portion of that capacity utilization? What would third-party revenues look like in 2027 relative to this year?
Rhone Resch
Chief Strategy Officer
When you say third party, what do you mean in that context?
Amit Dayal
Analyst, HC Wainwright
You know, from your breakdown.
Crocker Colson
Investor Relations
Are you talking about the mix of third party versus internal? Is that what you're talking about? Yes. I think maybe, I don't know, Simon, are you on? Do you want to opine on that?
Simon Shi
Senior Advisor to the Board
Yes. Yeah, sure. Thanks, Amir. Thanks for the question. Actually, looking to 2027, I would think, you know, almost all of our revenue will be from third party.
Amit Dayal
Analyst, HC Wainwright
Okay, understood.
Simon Shi
Senior Advisor to the Board
Do we expect to have all the shipments from the committee? I'm here, I'm here. Yes, yes, yes.
Crocker Colson
Investor Relations
So, I mean, does that answer your questions?
Amit Dayal
Analyst, HC Wainwright
Yes, yes, I got it.
Crocker Colson
Investor Relations
Okay, got it. Great. So, operator, I think we have another person in queue.
Matt
Conference Call Operator
Your next question comes from the line of Philip Shen with Roth Capital Markets. Philip, your line is open. Please go ahead.
Philip Shen
Analyst, Roth Capital Markets
Hey, guys. Thanks for taking my questions. Wanted to dig into the detention situation a little more, just kind of more color on You guys talked about shipments have been released, but can you give us some color on like have all shipments been released? Are any shipments still being detained? How is the flow of material or cells right now? And if product is still detained, what's the timeline of that release? Do you expect that eventually no product will be detained and when that might be? Thanks.
Rhone Resch
Chief Strategy Officer
Sure, I'll jump. This is Rhone. Good morning, Phil. What I want to do is kind of talk a little bit about CBP and the circumvention case together because they do kind of play, obviously, from a supply perspective. Thank you for having me. We have a very clear, transparent line of communication about our imports. We obviously have a very clean line of supply chain with respect to our polysilicon, where it's mined, where it's produced. We expect that CBP will continue to ask questions and look at various import shipments from time to time. But at this point in time, the detentions from CBP are not a restriction for us. Everything is released. The restriction is more on the lines of the uncertainty associated with the circumvention case. And so because that is sitting out there, there is uncertainty as to if those imports from Ethiopia would be tariffed or not. And so we are not bringing in cells because of that uncertainty. We're working closely with Commerce, as I mentioned. We've submitted our questionnaire. We're having, you know, kind of direct communication with them to try to get some clarity with respect to this particular case. But at this point in time, the detentions, or I should say the imports are not affected by the CBP detentions. They're more being impacted by the uncertainty associated with the circumvention case.
Philip Shen
Analyst, Roth Capital Markets
Great. That clarifies it for me. Thank you, Ron. And then You guys mentioned on your call or your remarks earlier that you have enough cells imported to meet your 27 demand. And so I wanted to connect with you on, you know, what does that mean for, like, can you sketch out what 2027 financially might look like? And then if you need to bring in more cells, you know, what would that be for 2028? Thanks.
Rhone Resch
Chief Strategy Officer
Simon, do you want to talk a little bit about the cell supply? So our cell supply, it meets our commitments from all of our customers today. Go ahead, Simon.
Simon Shi
Senior Advisor to the Board
Yeah, that is correct. Actually, if you look in our book, I think what's reflected in the book is a rapid buildup of our prepayments. and Working Capital, which are used towards to support the shipment commitment of our Houston manufacturer next year. So that to simply address your question, I think we are already looking to, you know, full operation or nearly full operation for next year for all our capacity in Houston module manufacturer next year. and that's already being supported by our raw material supply chain. So we are very confident about the shipment and our performance for next year. And you just mentioned about 2028. Hopefully, starting from 2028, as we planned, we will have our Houston-made sales coming out to support our manufacturing Houston modules too.
Rhone Resch
Chief Strategy Officer
I think the other piece is we'll have clarity on the circumvention case, obviously, and then we'll be able to import from Ethiopia fully, right? So that's a four gigawatt cell line as well. So I think by 2028, obviously, we'll have both production domestically as well as greater imports from our Ethiopia facility.
Philip Shen
Analyst, Roth Capital Markets
Great. Thank you. And then just an update on the Commerce Preliminary Determination Are you guys still expecting December 10th for the preliminary determination there? Can you just give us an update on the timeline of the ADCVD? Has any of that changed? Thanks.
Rhone Resch
Chief Strategy Officer
Well, that's certainly kind of at least statutorily what they're required to do. And so, you know, we fully expect and they're moving forward, right, with respect to the questionnaires responding to our answers. And the process is usually kind of back and forth at this point, Phil. So they will come back with additional questions. We'll answer them. So we would expect that they would stick to that deadline. However, as we've seen in other cases, sometimes it does get delayed. They're a little bit understaffed. We do not have any clarity from them about a schedule other than what they are required to do statutorily, which is, as you mentioned, December 10th.
Philip Shen
Analyst, Roth Capital Markets
Okay, got it. Thanks. And then from a customer standpoint, can you give us a sense for how those discussions are going? and how much of 27 modules or module capacity remains to be available, to be booked? It sounds like you're mostly sold out for next year, but if you can give us a rough percentage, that would be great. And then can you talk about module pricing? How has that changed in the past two or three months since the August PollySilicon232 announcement came out.
Simon Shi
Senior Advisor to the Board
Thanks. Phil, let me take this one. First of all, like I said, we have either already sold or in the process of selling for the capacity of next year from Houston. We do reserve a very limited buffer for the new orders to come in. or to reflect you know with a price to be more reflectible to the market demand so back to your question I think a current audible can a current sales opportunity already filled up all our capacity for next year but we do have let's say 23 20 percent less than 20 percent We are looking to mid 30s for the sales for next year, early next year and to high 30s. for the rest of next year in terms of shipment timing.
Philip Shen
Analyst, Roth Capital Markets
Okay. So this is already priced in contractually. So mid-30s for the first half of next year's sales volume and then high 30 cents per watt for the back half of next year, correct?
Simon Shi
Senior Advisor to the Board
That is correct. That's the current audits where we are taking. But like I said, we do keep a small portion in hand, hopefully to see a better sense of commercial opportunity in the future.
Philip Shen
Analyst, Roth Capital Markets
Okay, great.
Simon Shi
Senior Advisor to the Board
Thank you.
Philip Shen
Analyst, Roth Capital Markets
Have you started negotiating 2028? And where's the price for an imported cell and US cell module there?
Simon Shi
Senior Advisor to the Board
I think 2028 will be a more reflecting of the 232 policy, which will be over 40 cents. That's the range we're talking, over 40 cents, 40 to 45.
Philip Shen
Analyst, Roth Capital Markets
Right. And that over 40 cents, is that for an imported cell with U.S. main module?
Simon Shi
Senior Advisor to the Board
Actually, there is a blend. Basically, for this price, what we discussed with our customer is a blend of use of domestic and foreign part of the cell.
Philip Shen
Analyst, Roth Capital Markets
Okay. Right, because as you ramp up in 28, your humble cell facility, I got to imagine that that could be even mid to high 40 cents a watt. for the U.S. Main Cell and U.S. Module, correct? That is correct. Yeah, okay. Okay, thanks. And then maybe a couple more and then I'll pass it on. As it relates to the on-shoring offset plan, what's the latest timing on when you might receive news on a formal or official plan? The effective date of the Polysilicon 232 tariff is December 4th. So do you expect it before then, after then, or coincidence? Thanks.
Rhone Resch
Chief Strategy Officer
Yeah, I'll jump in here, Phil. So in my conversations with Commerce, they're producing the guidance document for submitting plans. Junsei Ryu, Rhone Resch, Takahiko Onozuka And we've had multiple conversations with them about specifically what our plan is, but we will still, as without everybody, have to submit kind of in that format that they are requiring. We don't expect it to be radically different than what they did for pharmaceuticals, for example. So our proposal is very much in line with what they're putting together at this point in time. They have not approved any plans at this point. They're having conversations with other companies. The feedback they had with us is, hey, you guys are right at the front of the pack with a couple of others, but that they probably won't be approving plans much before December 4th. They'll continue to happen kind of through the first quarter of 2027 and beyond. But again, our goal here is to get certainty. And so we will be working very closely with commerce, both after the guidance comes out, as well as, you know, kind of broadly speaking with the team to make sure that they're comfortable with the structure we're using. Because, again, as we mentioned, we're doing something that's a little bit different as a company. You know, we're importing our own cells and we're planning to onshore manufacturing in the U.S. in a fairly significant way.
Philip Shen
Analyst, Roth Capital Markets
Great. Thanks, Rhone. Last question for me. This is on margins. You know, the margins in Q3 were much lower than we were expecting at 16-ish percent gross margins. How do you see them kind of trending for Q4? And then how would you expect them to trend as you get up to higher volume in Q1, Q2, and Q3 next year, assuming the Ethiopia case goes in your favor? Thanks.
Simon Shi
Senior Advisor to the Board
Do you want me to take this one? Sure. Thanks, guys. Phil, let me take this one. First of all, I think the slight drop of margin for Q3 really reflect the mix of the product category we sell. I mean, as Ron mentioned, we slowed down the shipment from our cell factory in Q3, which which lead to a higher percentage of our total sales coming from module in Q3. That explains why the overall margin level is lower than before. Speaking of Q4, we are hoping to get a preliminary results from Commerce regarding the circumvention which will optimize our whole operation level. in both Ethiopia and also in the U.S., but it's hard for us to make a comment at a moment. But looking to 2027, like Rhone said, we have a strategy to address the circumvention investigation, and hopefully if we have a – hopefully if commerce follows their proceedings, on the ruling, and we can have a full resume of our operation from Ethiopia, and the margin will go back to close to the previous margin, which was more than 20%. And also, just to point out one thing here, even for our manufacturer, Inside the U.S., in Houston, our margin is double digit. Our margin for margin is also double digit. Hugh.
Rhone Resch
Chief Strategy Officer
I think that's a really important point.
Crocker Colson
Investor Relations
I do also want to clarify that the Q3, I don't believe, has any contribution from 45X and how that could change things in the future.
Simon Shi
Senior Advisor to the Board
That's correct. That's for relevant inputs, Crocker, actually. I think there was no contribution from whatsoever any 45X in Q3, in the Q3 margin and the Q3 overall performance financial number. But we are happy to tell you that actually our first offset from the tax credit of last year has been approved. So this is a significant movement for our Fortify Risk Qualification. Yeah, so combined... Yeah, Ron, please go ahead.
Rhone Resch
Chief Strategy Officer
I was going to say, just combined, Phil, when you think about it, if our margins are mostly driven this quarter by module sales, and we're still at 16.6%, and it's As Simon pointed out, we're double digit margins for just producing modules, and that doesn't include 45X. That's some pretty efficient manufacturing that we have going on. Great. Thanks for the call, guys. I'll pass it on.
Philip Shen
Analyst, Roth Capital Markets
Thanks all.
Matt
Conference Call Operator
There are no further questions at this time. We have reached the end of the Q&A session. I will now hand the call back to Crocker for closing remarks.
Crocker Colson
Investor Relations
Thanks so much to everybody. We appreciate you taking the time to join us on the call today. Please feel free to reach out to me with any questions for management that we couldn't cover on today's call. or if you'd like to meet with management at the RE Plus Solar Conference in Las Vegas this week, please let us know or on your future investor trips to the United States. Thanks again and look forward to coming back to you to talk about fourth quarter. That's it, operator.
Matt
Conference Call Operator
This concludes today's call. Thank you for attending. You may now disconnect.